Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kentucky BioProcessing (KBP), now branded as KBio, specializes in using plants as biofactories to produce therapeutic proteins and bioactive compounds. Their RP3 platform enables rapid, scalable, and sustainable manufacturing of biologics. They operate globally with strategic partnerships and are recognized leaders in plant-based biomanufacturing. While they do not disclose a proprietary drug pipeline, they provide contract services supporting research through clinical stages for partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kentucky BioProcessing.